Message from the editors to our reviewers

TY - JOUR

T1 - Message from the editors to our reviewers

AU - Gross, Robert A.

AU - Knopman, David S.

AU - Cascino, Gregory D.

AU - Corboy, John R.

AU - Elkind, Mitchell S.V.

AU - Engel, Andrew G.

AU - Mink, Jonathan W.

AU - Ransohoff, Richard M.

AU - Uitti, Ryan J.

AU - Worrall, Bradford B.

N1 - Funding Information: Gregory D. Cascino, MD, is coinvestigator of a study sponsored by NeuroPace, Inc., Sunnyvale, CA (RNS in Partial Epilepsy) and is supported by grant NS53998–03 (The Epilepsy Phenome/Genome Project) . He receives an honorarium from the AAN as Associate Editor of Neurology®. Funding Information: Richard M. Ransohoff, MD, conducts research supported by the NIH, the National MS Society, the Nancy Davis Center without Walls, Williams Family Foundation for MS Research, Chemocentryx, and Biogen-Idec. Dr. Ransohoff has received fees for pre-clinical consulting or honoraria for academic presentations from Novartis, Biogen-Idec, Pfizer, and Teva. He serves on Scientific Advisory, Medical Advisory, or Safety Monitoring Boards for Chemocentryx, Vertex, Merck, Glaxo Smith Kline, and Johnson & Johnson. As an Associate Editor of Neurology®, he receives an honorarium from the AAN. Funding Information: John R. Corboy, MD, FAAN, conducts research supported by the NIH, the National MS Society, Juvenile Diabetes Research Foundation, Immune Tolerance Network (NIAID), Genentech, Novartis, Eli Lilly, Bio-MS, Orasi, and Celgene Therapeutics, and has been a consultant for Celgene Therapeutics and Teva neurosciences. Dr. Corboy has received honoraria for speaking from ProCE and the Rocky Mountain MS Center. He is a Section Editor for Neurology Today and receives an honorarium from the AAN as an Associate Editor of Neurology®. Funding Information: Jonathan W. Mink, MD, PhD, has received research support from NIH/NINDS and the CDC. Dr. Mink serves on the Board of Scientific Counselors, NINDS. Dr. Mink has received travel funding from the Tourette Syndrome Association. He is an Editorial Board Member of Continuum, Pediatric Neurology, and the Journal of Child Neurology. Dr. Mink has received honoraria from the Tourette Syndrome Association, and receives an honorarium as Associate Editor of Neurology®. Funding Information: Robert A. Gross, MD, PhD, FAAN, has received research funding from the Department of the Army and UCBPharma. He is supported for educational endeavors from the University of Rochester Medical Center's Clinical and Translational Science Award from the NIH. Dr. Gross has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus. He has served on the speakers' bureaus for Abbott, UCB, and GlaxoSmithKline and has received consultant fees from GlaxoSmithKline and Harris Interactive. Since his appointment as Editor-in-Chief, Dr. Gross has ceased participation in industry-sponsored clinical trials and speakers' bureaus. He receives an honorarium from AAN as Editor-in-Chief of Neurology®. Funding Information: Ryan J. Uitti, MD, FAAN, has received research funding from the NIH, PARRF, PSG, Noscira, Inc., and Advanced Neuromodulation Systems, Inc. Dr. Uitti has served as a Continuing Medical Educator for the AAN. His institution has received annual royalties from the licensing of the technology related to PARK8/LRRK2 greater than the federal threshold for significant financial interest; Dr. Uitti has not received any royalties. Dr. Uitti receives an honorarium as Associate Editor of Neurology®.

PY - 2011/7/5

Y1 - 2011/7/5

UR - http://www.scopus.com/inward/record.url?scp=80051485107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051485107&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3182260341

DO - 10.1212/WNL.0b013e3182260341

M3 - Editorial

AN - SCOPUS:80051485107

SN - 0028-3878

VL - 77

SP - 5

EP - 11

JO - Neurology

JF - Neurology

IS - 1

ER -